These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Overview of the nature of vasoconstriction in arterial grafts for coronary operations. He GW, Yang CQ, Starr A. Ann Thorac Surg; 1995 Mar; 59(3):676-83. PubMed ID: 7887711 [Abstract] [Full Text] [Related]
3. Functional comparison between the human inferior epigastric artery and internal mammary artery. Similarities and differences. He GW, Acuff TE, Ryan WH, Yang CQ, Mack MJ. J Thorac Cardiovasc Surg; 1995 Jan; 109(1):13-20. PubMed ID: 7815788 [Abstract] [Full Text] [Related]
4. Contractility of the human internal mammary artery at the distal section increases toward the end. Emphasis on not using the end of the internal mammary artery for grafting. He GW. J Thorac Cardiovasc Surg; 1993 Sep; 106(3):406-11. PubMed ID: 8361180 [Abstract] [Full Text] [Related]
5. Synergistic effect of nisoldipine and nitroglycerin on human internal mammary artery. Liu JJ, Johnston CI, Buxton BF. J Pharmacol Exp Ther; 1994 Jan; 268(1):434-40. PubMed ID: 8301585 [Abstract] [Full Text] [Related]
6. The comparison of the responsiveness of human isolated internal mammary and gastroepiploic arteries to levcromakalim: an alternative approach to the management of graft spasm. Akar F, Uydeş-Dogan BS, Tufan H, Aşlamaci S, Köksoy C, Kanzik I. Br J Clin Pharmacol; 1997 Jul; 44(1):49-56. PubMed ID: 9241096 [Abstract] [Full Text] [Related]
9. Inhibition of vasoconstriction by phosphodiesterase III inhibitor milrinone in human conduit arteries used as coronary bypass grafts. He GW, Yang CQ. J Cardiovasc Pharmacol; 1996 Aug; 28(2):208-14. PubMed ID: 8856475 [Abstract] [Full Text] [Related]
10. Potential greater than additive vasorelaxant actions of milrinone and nitroglycerin on human conduit arteries. He GW, Yang CO, Gately H, Furnary A, Swanson J, Ahmad A, Floten S, Wood J, Starr A. Br J Clin Pharmacol; 1996 Feb; 41(2):101-7. PubMed ID: 8838435 [Abstract] [Full Text] [Related]
14. Inhibition of vasoconstriction by angiotensin receptor antagonist GR117289C in arterial grafts. Liu MH, Floten HS, Furnary AP, Yim AP, He GW. Ann Thorac Surg; 2000 Dec; 70(6):2064-9. PubMed ID: 11156121 [Abstract] [Full Text] [Related]
15. The in vitro effects of phosphodiesterase inhibitors on the human internal mammary artery. Salmenperä M, Levy JH. Anesth Analg; 1996 May; 82(5):954-7. PubMed ID: 8610905 [Abstract] [Full Text] [Related]
16. Inhibition of vasoconstriction by potassium channel opener aprikalim in human conduit arteries used as bypass grafts. He GW, Yang CQ. Br J Clin Pharmacol; 1997 Oct; 44(4):353-9. PubMed ID: 9354310 [Abstract] [Full Text] [Related]
17. Inhibition of vasoconstriction by AJ-2615, a novel calcium antagonist with alpha(1)-adrenergic receptor blocking activity in human conduit arteries used as bypass grafts. Liu MH, Floten SH, Yang Q, He GW. Br J Clin Pharmacol; 2001 Sep; 52(3):279-87. PubMed ID: 11560560 [Abstract] [Full Text] [Related]
18. The vasodilator effects of clevidipine on human internal mammary artery. Huraux C, Makita T, Szlam F, Nordlander M, Levy JH. Anesth Analg; 1997 Nov; 85(5):1000-4. PubMed ID: 9356090 [Abstract] [Full Text] [Related]
19. Effects of selected vasoconstrictor agonists on isolated omental artery from premenopausal nonpregnant women and from normal and preeclamptic pregnant women. Belfort MA, Saade GR, Suresh M, Kramer W, Vedernikov YP. Am J Obstet Gynecol; 1996 Feb; 174(2):687-93. PubMed ID: 8623808 [Abstract] [Full Text] [Related]
20. Augmented contraction of the human isolated coronary artery by sumatriptan: a possible role for endogenous thromboxane. Maassen VanDenBrink A, Bax WA, Ferrari MD, Zijlstra FJ, Bos E, Saxena PR. Br J Pharmacol; 1996 Nov; 119(5):855-62. PubMed ID: 8922732 [Abstract] [Full Text] [Related] Page: [Next] [New Search]